Rallybio Corporation announced that it has appointed Wendy K. Chung, M.D., Ph.D., to its Board of Directors.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.51 USD | -4.43% | -14.04% | -38.49% |
05-15 | JPMorgan Downgrades Rallybio to Neutral From Overweight | MT |
05-09 | Rallybio Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-38.49% | 65.49M | |
+42.32% | 58.71B | |
-3.12% | 41.31B | |
+36.25% | 39.2B | |
-10.22% | 27.4B | |
+10.48% | 26.55B | |
-22.45% | 18.98B | |
+1.07% | 12.51B | |
+26.19% | 12.08B | |
+20.74% | 11.94B |
- Stock Market
- Equities
- RLYB Stock
- News Rallybio Corporation
- Rallybio Corporation Appoints Wendy K. Chung, M.D., Ph.D., to Its Board of Directors